ATCC 25922 Escherichia Coli (Migula) Castellani and Chalmers

In the world of microbiology, very few bacterial species achieve gold standard status like Escherichia coli ATCC 25922. This Gram-negative swab, maintained and distributed by the American Type Culture Collection (ATCC), serves as a cornerstone for quality control in laboratories worldwide. First isolated from a human clinical specimen in 1946, ATCC 25922 has transcended its humble origins to become an indispensable tool in antimicrobial susceptibility testing, research, and diagnostic confirmation. Its reliability, well-characterized genome, and predictable behavior make it a go-to reference for ensuring the accuracy of antibiotics, culture media, and testing protocols.

ATCC 25922's history begins with its initial isolation from a clinical sample by the U.S. Food and Drug Administration (FDA) in 1946. Initially cataloged under various names, this strain was registered in the ATCC collection under the strain number 25922. Over the decades, it was shared in global data repositories and referred to by different names. Towards the end of the 20th century, ATCC 25922's usefulness in standardization efforts brought it to prominence. As antibiotic resistance became a global crisis, the need for consistent reference strains gained importance, and major organizations in this field solidified its role in clinical microbiology by approving this strain as a benchmark for minimum inhibitory concentration testing.

Escherichia coli ATCC 25922 exemplifies the typical characteristics of non-pathogenic Escherichia coli strains: it is a motile, facultative anaerobe that ferments lactose, grows optimally at 37 degrees Celsius, and forms characteristic pink colonies on MacConkey agar. However, what sets it apart is its phenotypic stability. Researchers note, however, that repeated passages in the stock can alter minimum inhibitory concentration levels, recommending agar maintenance and immediate freezing of the stock for consistency.

Genetically, the entire genome of the strain was sequenced and assembled in 2014. The accessibility of the genome has supported studies on its metabolic pathways, virulence factors (or their absence), and evolutionary adaptations.

ATCC 25922 is primarily known for its use in antimicrobial susceptibility testing. It is the recommended quality control organism for a range of antibiotics, including penicillins, cephalosporins, aminoglycosides, and fluoroquinolones. Laboratories use this method to validate disk diffusion and broth dilution methods and ensure that results are consistent with breakpoint values.

ATCC 25922 excels in antimicrobial susceptibility testing, as well as in environmental performance testing, dye validation, and identification kit evaluations. Its purified genomic DNA supports molecular biology, from PCR testing to next-generation sequencing. In research, it serves as a model for studying bacterial stress responses.

ATCC 25922 embodies the paradox of Escherichia coli, a bacterium that harmlessly colonizes the gut but poses a risk when it becomes disordered. As a reference strain, it democratizes microbiology and allows various laboratories to standardize practices against increasing antimicrobial resistance. Its genome sequence accelerates comparative genomic studies, revealing how lab-adapted strains differ from wild-type strains.

Looking to the future, thanks to synthetic biology, ATCC 25922 could evolve into variants designed for vaccine development or bioremediation. However, its enduring value lies in its simplicity; a frozen vial reminds us that reliable science begins with a consistent foundation. In an age of microbial uncertainty, this 78-year-old strain remains a symbol of reproducibility.

ATCC 25922 (Escherichia coli) is one of the most important bacterial strains in clinical microbiology and laboratory quality control for the following key reasons:

• ATCC 25922 is the global gold standard for antimicrobial susceptibility testing: it is the official quality control strain recommended by relevant organizations worldwide for virtually all disk diffusion and minimum inhibitory concentration testing methods. Every day, thousands of clinical laboratories worldwide run ATCC 25922 with patient samples to verify that their antibiotics, disks, media, and equipment are performing correctly. The expected minimum inhibitory concentration and zone diameter ranges are published in tables and updated annually. If a laboratory's results for ATCC 25922 fall outside these ranges, all patient results from that study are considered invalid.
• It tests a wide range of antibiotics: It has reproducible, moderate susceptibility against most major antibiotic classes. This is ideal for detecting small errors in test performance that might miss fully susceptible or fully resistant strains.
• It is highly stable and well-characterized: When properly maintained, it is phenotypically and genotypically stable. Its complete genome has been sequenced and is publicly available, used as a reference in bioinformatics and molecular studies. It is a safe (biosafety level 1), non-pathogenic, lactose-fermenting species that is easy to cultivate and gives clear reactions in common culture media.
• Required for regulatory and accreditation compliance: It is a mandatory strain for accreditation bodies such as the American College of Pathologists, the ISO 15189 standard, and many national regulatory agencies. Commercial manufacturers of antibiotic discs, automated antimicrobial susceptibility testing systems, and susceptibility testers must validate their products using ATCC 25922.
• It serves as a benchmark for new methods and research: Any new susceptibility testing method, culture medium, or antibiotic must be validated against ATCC 25922 results. It is widely used in research on antibiotic resistance mechanisms, biofilm formation, small colony variants, and bacterial stress responses.

Consequently, without ATCC 25922 (and other important strains such as ATCC 25923 for staphylococci or ATCC 27853 for Pseudomonas), modern clinical microbiology laboratories cannot reliably report whether a patient's infection is susceptible or resistant to antibiotics. This strain is the most frequently used reference strain in diagnostic microbiology worldwide.

For many years, our organization, with its competent and experienced staff, has been understanding the needs of its clients, providing the advanced testing services they require, and assisting in the establishment, implementation, and improvement of management systems. Within this framework, we also provide testing services to businesses in accordance with the “ATCC 25922 Escherichia coli (Migula) Castellani and Chalmers” standard.